References
- Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O'Keeffe M et al 2004. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. European Journal of Clinical Pharmacology 60:635–641.
- Han JY, Yang JH, Chung JH, Choi JS, Ahn HK, Ryu HM et al 2005. Teratogen risk counselling by internet: a prospective cohort study. Journal of Obstetrics and Gynaecology 25:427–431.
- Ngan Kee WD, Khaw KS, Tan PE, Ng FF, Karmakar MK. 2009. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 111:506–512.
- Nishikawa T, Bruyere HJ Jr, Takagi Y, Gilbert EF, Uno H. 1985. Cardiovascular teratogenicity of ephedrine in chick embryos. Toxicology Letters 29:59–63.
- Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ. 1996. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54: 84–92.
- Werler MM, Mitchell AA, Shapiro S. 1992. First trimester maternal medication use in relation to gastroschisis. Teratology 45:361–367.
- Werler MM, Sheehan JE, Mitchell AA. 2002. Maternal medication use and risks of gastroschisis and small intestinal atresia. American Journal of Epidemiology 155:26–31.
- Werler MM, Sheehan JE, Mitchell AA. 2003. Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology 14:349–354.
- Werler MM. 2006. Teratogen update: pseudoephedrine. Birth Defects Research. Part A, Clinical and Molecular Teratology 76:445–452.
- Wilcox AJ, Baird DD, Weinberg CR. 1999. Time of implantation of the conceptus and loss of pregnancy. New England Journal of Medicine 340:1796–1799.
- Yang JH, Kim YJ, Chung JH, Kim MY, Ryu HM, Ahn HK et al 2004. A multi-center study for birth defect monitoring systems in Korea. Journal of Korean Medical Science 19:509–513.